secwatch.observer — SEC 8-K summary
======================================

Issuer:     Benitec Biopharma Inc. (BNTC)
CIK:        0001808898
Form:       8-K
Filed at:   2023-10-16T23:59:59+00:00
Accession:  0001193125-23-257001
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Benitec Biopharma approves $273K bonus for CEO and $117K for Executive Director
-------------------------------------------------------------------------------

- Compensation Committee approved discretionary bonus of $273,000 for CEO Jerel Banks for FY 2023.
- Executive Director Megan Boston awarded $116,928 (converted from AUD at ~0.64 USD/AUD).
- Bonuses relate to performance during fiscal year ended June 30, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808898/000119312523257001/0001193125-23-257001-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808898/000119312523257001/d529125d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-257001

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer